연구성과로 돌아가기

2023 연구자 정보 (975 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Jeon, So-Yeon
(Jeon, SY)
Jeonbuk Natl Univ, Dept Internal Med, Med Sch, Jeonju, South Korea

[JCR상위 50.5] Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen SCIE 50.5 ONCOLOGY jkk21c@knu.ac.kr;
Jeon, Wan
(Jeon, W)
제1저자 Dongnam Inst Radiol & Med Sci, Dept Radiat Oncol, Busan, South Korea
Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea


[JCR상위 50.5] Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation SCIE 50.5 ONCOLOGY sihochoi@dirams.re.kr;tgson@dirams.re.kr;kskim.cirt@snu.ac.kr;
Jeong, Dong Hyeok
(Jeong, DH)
Dongnam Inst Radiol & Med Sci, Res Ctr, Busan, South Korea

[JCR상위 50.5] Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation SCIE 50.5 ONCOLOGY sihochoi@dirams.re.kr;tgson@dirams.re.kr;kskim.cirt@snu.ac.kr;
Jo, Hong Jae
(Jo, HJ)
Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Surg, Sch Med, Busan, South Korea

[JCR상위 50.5] Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen SCIE 50.5 ONCOLOGY jkk21c@knu.ac.kr;
Jung, Se Yeon
(Jung, SY)
Dongnam Inst Radiol & Med Sci, Res Ctr, Busan, South Korea

[JCR상위 50.5] Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation SCIE 50.5 ONCOLOGY sihochoi@dirams.re.kr;tgson@dirams.re.kr;kskim.cirt@snu.ac.kr;
Kang, Myoung Hee
(Kang, MH)
Gyeongsang Natl Univ, Coll Med, Dept Internal Med, Div Hematol Oncol,Changwon Hosp, Samjeongja Ro 11, Chang Won, South Korea

[JCR상위 50.5] Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen SCIE 50.5 ONCOLOGY jkk21c@knu.ac.kr;
Kim, Dong Han
(Kim, DH)
Sanofi Korea, Med Affairs Oncol, Seoul, South Korea
GSK Korea, Seoul, South Korea
C-4288-2013
Kim, Donghee
0000-0002-4507-2038
Kim, Dong Han
[JCR상위 50.5] Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen SCIE 50.5 ONCOLOGY jkk21c@knu.ac.kr;
Kim, Hee Kyung
(Kim, HK)
Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Internal Med, Div Oncol,Coll Med, Cheongju, South Korea

[JCR상위 50.5] Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen SCIE 50.5 ONCOLOGY jkk21c@knu.ac.kr;
Kim, Hyun
(Kim, H)
Dongnam Inst Radiol & Med Sci, Res Ctr, Busan, South Korea

[JCR상위 50.5] Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation SCIE 50.5 ONCOLOGY sihochoi@dirams.re.kr;tgson@dirams.re.kr;kskim.cirt@snu.ac.kr;
Kim, In Ah
(Kim, IA)
Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea
Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Radiat Oncol, Seongnam, South Korea
Seoul Natl Univ, Dept Radiat Oncol, Bundang Hosp, Seongnam, South Korea
J-5426-2012
Kim, In

[JCR상위 50.5] Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation
[JCR상위 28.4] Suggestions for Escaping the Dark Ages for Pediatric Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy: Analysis of Prognostic Factors from the National Multicenter Study
SCIE 28.4 ONCOLOGY sihochoi@dirams.re.kr;tgson@dirams.re.kr;kskim.cirt@snu.ac.kr;
YHI0225@yuhs.ac;suhchangok@cha.ac.kr;
Kim, Jin Soo
(Kim, JS)
Chungnam Natl Univ, Coll Med, Dept Surg, Sejong Hosp, Sejong, South Korea ABF-3773-2021
Kim, Heui-Soo

[JCR상위 50.5] Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen SCIE 50.5 ONCOLOGY jkk21c@knu.ac.kr;
Kim, Jung-Han
(Kim, JH)
Hallym Univ, Kangnam Sacred Heart Hosp, Dept Internal Med, Coll Med, Seoul, South Korea I-9389-2017
KIM, SUN

[JCR상위 50.5] Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen SCIE 50.5 ONCOLOGY jkk21c@knu.ac.kr;
Kim, Kyung Su
(Kim, KS)
교신저자 Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea
Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea
AEP-3965-2022
Kim, Kyoungmi

[JCR상위 50.5] Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation SCIE 50.5 ONCOLOGY sihochoi@dirams.re.kr;tgson@dirams.re.kr;kskim.cirt@snu.ac.kr;
Kim, Won-Tae
(Kim, WT)
Dongnam Inst Radiol & Med Sci, Res Ctr, Busan, South Korea

[JCR상위 50.5] Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation SCIE 50.5 ONCOLOGY sihochoi@dirams.re.kr;tgson@dirams.re.kr;kskim.cirt@snu.ac.kr;
Lee, Chae Young
(Lee, CY)
Dongnam Inst Radiol & Med Sci, Res Ctr, Busan, South Korea

[JCR상위 50.5] Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation SCIE 50.5 ONCOLOGY sihochoi@dirams.re.kr;tgson@dirams.re.kr;kskim.cirt@snu.ac.kr;
페이지 이동: